Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 20 February 2023 to Question 148627 on Voluntary Scheme for Branded Medicines Pricing and Access, which (a) industry bodies, (b) patient organisations and (c) relevant civil society organisations have been invited to the workshops.

The following organisations have been invited to one or more of the stakeholder workshops:

Industry bodies

- Association of the British Pharmaceutical Industry;

- British Generic Manufacturers Association;

- Ethical Medicines Industry Group; and

- BioIndustry Association.

Patient organisations and civil society organisations

- Cancer52;

- The Blood Cancer Alliance;

- The Charity Medicines Access Coalition;

- National Voices;

- The Patients Association;

- Alzheimer’s Research UK;

- Anthony Nolan;

- Cystic Fibrosis Trust;

- Genetic Alliance UK;

- The Association of Medical Research Charities;

- Breast Cancer Now;

- Myeloma UK;

- Office of Health Economics;

- King’s Fund; and

- NHS Confederation.